Lynn Roy, Karen D. Cowden Dahl. Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer? (2018) Cancers.
Lynn Roy, Alexander Bobbs, Rachel Sattler, Jeff L. Kurkewich, Paige B. Dausinas, Prakash Nallathamby, Karen D. Cowden Dahl. CD133 promotes adhesion to the ovarian cancer metastatic niche. (2018) Cancer Growth Metastasis.
Mitra A, Davis DA, Tomar S, et al. In vitro tumor growth of high-grade serous ovarian cancer cell lines. (2015) Gynecologic Oncology.
Lynn Roy, Emmanuel Bikorimana, Danica Lapid, Hyewon Choi, Tan Nguyen, Richard Dahl. MiR-24 is required for hematopoietic differentiation of mouse embryonic stem cells. (2015) PLOS Genetics.
Lynn Roy, Serene J. Samyesudhas, Martin Carrasco, Jun Li, Richard Dahl, and Karen D. Cowden Dahl. ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature. (2014) Oncotarget.
Serene J Samyesudhas, Lynn Roy, Jun Li, Karen Cowden Dahl. Dual roles for ARID3B in cancer: ARID3B expression in differentiated epithelium decreases during cancer while moderate expression of ARID3B in ovarian cancer predicts relapse. (2014) Gene.
Lynn Roy, Claudia A. McDonald, Chao Jiang, Anthony J. Zeleznik, Todd A. Wyatt, Xiaoying Hou, John S. Davis. Convergence of cAMP/PKA and GSK3ß/ß-catenin signaling in progesterone synthesis. (2009) Endocrinology